首页> 美国卫生研究院文献>Springer Open Choice >Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data
【2h】

Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data

机译:人囊性棘球cc虫病中阿苯达唑-亚砜的囊内浓度:对个别患者数据的系统评价和分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cystic echinococcosis (CE) is a widespread zoonosis caused by the species complex Echinococcus granulosus. Albendazole (ABZ)—the first-line anthelminthic drug for medical treatment of CE—is metabolized in vivo to the active derivative ABZ-sulphoxide (ABZ-SO). Target-site ABZ-SO concentrations in the hydatid cyst mediate the anthelminthic effect in CE. Primary outcome of this systematic review of individual patient data was the intra-cystic ABZ-SO concentration stratified by cyst size, location, calcification status and use of praziquantel. Studies reporting intra-cystic ABZ-SO concentrations in humans were identified by a systematic search. A pooled analysis of individual patient data was performed to assess intra-cystic concentrations. Pharmacokinetic data of 121 individual cysts were analysed. There was no correlation between plasma and intra-cystic ABZ-SO concentrations (rho = −0.03, p = 0.76). Intra-cystic drug concentrations were also not associated with sex and treatment duration. Use of praziquantel in combination with ABZ was associated with higher plasma (median 540 vs. 240 μg/L; p = 0.04) but not intra-cystic ABZ-SO concentrations (median 220 vs. 199 μg/L; p = 0.36). Relative drug concentrations in hepatic cysts were higher than in other cysts (0.8 vs. 0.4; p = 0.05). Intra-cystic concentrations were higher in calcified than non-calcified cysts (median 897 vs. 245 μg/L; p = 0.03). There was a trend towards higher intra-cystic concentrations in smaller sized cysts (β = −17.2 μg/L/cm; 95th CI, −35.9 to 1.6; p = 0.07). This study demonstrates that mean intra-cystic drug concentrations are similar to plasma concentrations on a population level. However, in individual patients plasma concentrations are not directly predictive for intra-cystic concentrations. The use of booster drugs was not associated with higher intra-cystic ABZ-SO concentrations in this analysis.Electronic supplementary materialThe online version of this article (doi:10.1007/s00436-016-5054-x) contains supplementary material, which is available to authorized users.
机译:囊性棘球co虫病(CE)是由物种复杂的细粒棘球caused虫(Echinococcus granulosus)引起的广泛人畜共患病。阿苯达唑(ABZ)是用于治疗CE的一线驱虫药,在体内被代谢成活性衍生物ABZ-亚砜(ABZ-SO)。包虫囊肿中目标部位的ABZ-SO浓度介导了CE的驱虫作用。对该患者数据进行系统回顾的主要结果是,囊肿内ABZ-SO浓度通过囊肿大小,位置,钙化状态和吡喹酮的使用进行分层。通过系统搜索确定了报告人囊内ABZ-SO浓度的研究。对单个患者数据进行汇总分析以评估囊内浓度。分析了121个囊肿的药代动力学数据。血浆和囊内ABZ-SO浓度之间没有相关性(rho ==-0.03,p == 0.76)。囊内药物浓度也与性别和治疗时间无关。吡喹酮与ABZ的联合使用可带来更高的血浆(中位数540vs.240μg/ L; p = 0.04),但与囊内ABZ-SO浓度无关(中位数220vs.199μg/ L; p = 0.36)。肝囊肿中的相对药物浓度高于其他囊肿(0.8 vs. 0.4; p = 0.05)。钙化囊肿的囊内浓度高于非钙化囊肿(中位897 vs.245μg/ L; p = 0.03)。在较小的囊肿中,囊内浓度有升高的趋势(β=-17.2μg/ L / cm; 95th CI,-35.9至1.6; p = 0.07)。这项研究表明,在人群水平上,平均囊内药物浓度与血浆浓度相似。但是,在个别患者中,血浆浓度不能直接预测囊内浓度。在该分析中,加强药物的使用与较高的囊内ABZ-SO浓度无关。电子补充材料本文的在线版本(doi:10.1007 / s00436-016-5054-x)包含补充材料,可用于授权用户。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号